Prospective, Non-randomized, 36-Month Study of Second-Generation Trabecular Micro-Bypass Stents with Phacoemulsification in Eyes with Various Types of Glaucoma

Prospective, Non-randomized, 36-Month Study of Second-Generation Trabecular Micro-Bypass Stents with Phacoemulsification in Eyes with Various Types of Glaucoma

Abstract Introduction The aim of this study was to assess 36-month outcomes after cataract surgery and implantation of two second-generation trabecular micro-bypass stents (iStent inject, Glaukos Corporation, San Clemente, CA, USA) into eyes with predominantly primary open-angle glaucoma (POAG) or p...

Full description

Bibliographic Details
Main Authors: Fritz H. Hengerer, Gerd U. Auffarth, Christoffer Riffel, Ina Conrad-Hengerer
Format: Article
Language:English
Published: Adis, Springer Healthcare 2018-11-01
Series:Ophthalmology and Therapy
Subjects:
Cataract
Glaucoma
Intraocular pressure
iStent inject
Microinvasive glaucoma surgery (MIGS)
PEX
Online Access:http://link.springer.com/article/10.1007/s40123-018-0152-8

Internet

http://link.springer.com/article/10.1007/s40123-018-0152-8

Similar Items